Nimodipine NEW
| Price | $31 |
| Package | 100mg |
| Supply Ability: | 10g |
| Update Time: | 2026-07-15 |
Product Details
| Product Name: Nimodipine | CAS No.: 66085-59-4 |
| Purity: 99.71% | Supply Ability: 10g |
| Release date: 2026/07/15 |
Product Introduction
Bioactivity
| Name | Nimodipine |
| Description | Nimodipine (BAY-e 9736), a 1, 4-dihydropyridine calcium channel blocker, acts primarily on vascular smooth muscle cells. |
| In vivo | Nimodipine (5-20 mg/kg, SC) suppresses in a dose-related manner self-administration both of cocaine and morphine contingent upon a nose-poke response. Nimodipine (10 mg/kg, SC), an L-type dihydropyridine Ca2+ channel antagonist, exhibits to completely block the establishment of conditioning of cocaine's effects, but only partially blocks sensitization to cocaine. |
| Storage | Keep away from direct sunlight, Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | Ethanol : 4.2 mg/mL (10.04 mM), Sonication is recommended. DMSO : 130 mg/mL (310.68 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 4 mg/mL (9.56 mM), Sonication is recommended. |
| Keywords | well-tolerated | orally | Nimodipine | Mineralocorticoid Receptor | light-sensitive | Inhibitor | inhibit | GlucocorticoidReceptor | Glucocorticoid Receptor | dihydropyridine | cerebrovascular | CalciumChannel | Calcium Channel | calcium | Ca2+ channels | Ca channels | Autophagy | AhR |
| Inhibitors Related | Stavudine | Aceglutamide | Hemin | 2,4,6-Tri-tert-butylphenol | Tamoxifen | Cysteamine hydrochloride | Guanidine hydrochloride | Hydroxychloroquine | Paeonol | Naringin | Alginic acid | Sildenafil citrate |
| Related Compound Libraries | Failed Clinical Trials Compound Library | Pain-Related Compound Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Neuroprotective Compound Library | Immunology/Inflammation Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Ion Channel Targeted Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP6Y
|
Sinoway Industrial co., ltd.
|
2026-07-20 | ||
|
VIP6Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2026-07-20 | ||
| $999.00 |
VIP2Y
|
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
|
2026-07-16 | |
| $31.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-07-15 | |
|
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2026-06-30 | ||
| $49.00 |
VIP7Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2025-12-24 | |
|
VIP9Y
|
Guangzhou PI PI BIOTECH INC
|
2025-12-19 | ||
| $33.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-04-30 | |
|
airuikechemical co., ltd.
|
2024-12-24 | |||
|
Changzhou Rokechem Technology Co., Ltd.
|
2023-06-22 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY